Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Replimune Group, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 107 | 1 | 102 | −4 |
| Shares | 39.1M | 4.46K | 40.0M | +884.0K (+2.3%) |
| Value | $665.0M | $76.0K | $700.2M | +$35.3M (+5.3%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Replimune Group, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 215,930 | $3.78M | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 10,718 | $187.0K | 0.00% |
| US Bancorp | 972 | $17.0K | 0.00% |
| Nisa Investment Advisors, LLC | 1,000 | $17.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 230 | $4.00K | 0.00% |
| Parallel Advisors, LLC | 6 | $0 | 0.00% |
| Dark Forest Capital Management LP | 5 | $0 | 0.00% |
Sold out (11)
Institutions that held Replimune Group, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Sphera Funds Management Ltd. | 212,640 | $3.61M |
| Qube Research & Technologies Ltd | 49,090 | $834.0K |
| Susquehanna International Group, LLP | 49,072 | $833.0K |
| Graham Capital Management, L.P. | 21,200 | $359.0K |
| Marshall Wace, LLP | 20,143 | $342.0K |
| D. E. Shaw & Co., Inc. | 18,922 | $321.0K |
| PDT Partners, LLC | 10,898 | $185.0K |
| ProShare Advisors LLC | 10,548 | $179.0K |
| Simplex Trading, LLC | 799 | $13.0K |
| Harel Insurance Investments & Financial Services Ltd. | 88 | $1.00K |
| Covestor Ltd | 13 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Replimune Group, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 4,463 | $76.0K |